|
Astra ends production of asthma inhaler
CNBC.com LONDON – AstraZeneca PLC is ending production of one version of its asthma drug Pulmicort immediately because of technical problems in manufacturing. Astra's announcement on Monday sent shares in its technology partner for the drug, SkyePharma, … Astra pulls asthma product, hitting SkyePharma |
View full post on asthma – Google News